ANAGREDEX anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagredex anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: crospovidone; lactose; lactose monohydrate; povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagredex capsules are indicated for the treatment of essential thrombocythaemia.

ANAGREDEX anagrelide (as hydrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagredex anagrelide (as hydrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: crospovidone; microcrystalline cellulose; lactose; lactose monohydrate; povidone; magnesium stearate; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagredex capsules are indicated for the treatment of essential thrombocythaemia.

ANAGRIDE anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagride anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose monohydrate; lactose; povidone; crospovidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagride capsules are indicated for the treatment of essential thrombocythaemia.

ANAGRIDE anagrelide (as hydrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagride anagrelide (as hydrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose; magnesium stearate; povidone; crospovidone; lactose monohydrate; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagride capsules are indicated for the treatment of essential thrombocythaemia.

AGRYLIN 0.5MG CAPSULES Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

agrylin 0.5mg capsules

takeda malaysia sdn bhd - anagrelide hydrochloride monohydrate -

Anagrelide STADA 0,5 mg, harde capsules Netherlands - English - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

anagrelide stada 0,5 mg, harde capsules

Anagrelide Zentiva 0,5 mg, harde capsules Netherlands - English - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

anagrelide zentiva 0,5 mg, harde capsules

Agrylin Australia - English - Department of Health (Therapeutic Goods Administration)

agrylin

shire australia pty ltd - anagrelide hydrochloride -

Agrylin Capsules 0.5mg Namibia - English - Namibia Medicines Regulatory Council

agrylin capsules 0.5mg

shire pharmaceuticals south africa (pty) ltd - anagrelide hcl monohydrate - capsules - each capsule contains anagrelide hydrochloride monohydrate 0,5mg

AGRYLIN 0.5 MG Israel - English - Ministry of Health

agrylin 0.5 mg

medison pharma ltd - anagrelide hydrochloride 0.5 mg - capsules - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.